(Benzotriazol-1-Yloxy)Dipyrrolidinocarbenium Hexafluorophosphate

We are (Benzotriazol-1-Yloxy)Dipyrrolidinocarbenium Hexafluorophosphate CAS:105379-24-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:(Benzotriazol-1-Yloxy)Dipyrrolidinocarbenium Hexafluorophosphate
CAS.NO:105379-24-6
Synonyms:1-[pyrrolidin-1-ium-1-ylidene(pyrrolidin-1-yl)methoxy]benzotriazole,hexafluorophosphate;O-(Benzotriazol-1-yl)-N,N,N',N'-bis(tetramethylene)uronium Hexafluorophosphate;HBPyU
Molecular Formula:C15H20F6N5OP
Molecular Weight:431.31600
 
Physical and Chemical Properties:
Melting point:176oC;
Boiling point:198oC;
Flash point:78oC;
 
HS Code: 2933990099
UN No.: UN1993
Hazard class: 3 categories 
Packing level: Class III
 
Specification:
Appearance:White crystal
Purity(HPLC):≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:As a condensation reagent

(Benzotriazol-1-Yloxy)Dipyrrolidinocarbenium Hexafluorophosphate


Related News: The drug review center will establish a registration platform and database for APIs, pharmaceutical excipients and pharmaceutical packaging materials, which means that the domestic drug substance DMF system is expected to be gradually implemented.130284-52-5 Over the years, large international pharmaceutical companies have gradually focused on the research and development and sales of patented drugs, and have gradually outsourced traditional products. Among them, most of the contractors are pharmaceutical companies in emerging countries.3144-09-0 China will use its national drug bulk-buy scheme to lower the price of drugs currently sold at higher prices compared with other markets, it said in an official statement.2-cloro-4,6-di (naftalen-1-il) -1,3,5-triazina CAS:78941-32-9 China will use its national drug bulk-buy scheme to lower the price of drugs currently sold at higher prices compared with other markets, it said in an official statement.Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders.

Related Products
Product Name
2-Amino-5-bromobenzotrifluoride View Details
2-Cyano-5-methylpyridine View Details
1,2-Bis(triethoxysilyl)ethane View Details
Nalpha-FMOC-L-Glutamine manufacturer 2-Furfurylthio-3-methylpyrazine manufacturer 2′-bromobiphenyl-3-carbonitrile manufacturer 2-(Methylsulfonyl)ethylamine Hydrochloride manufacturer 2,4-Dihydro-5-methyl-2-(4-methylphenyl)-3H-pyrazol-3-one manufacturer